| |
| |
|
| Insider
Information: |
Chang Joseph Y |
| Relationship: |
Director |
| City: |
Provo |
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
21,234 |
|
|
Indirect Shares
|
78,068 |
|
|
| Direct
Value |
$264,788 |
|
|
|
Indirect Value
|
$973,508 |
|
|
| Total
Shares |
99,302 |
|
|
| Total
Value |
$1,238,296 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
NU Skin Enterprises Inc |
NUS |
Chief Scientific Officer |
2023-03-02 |
21,234 |
2023-03-02 |
78,068 |
Premium* |
|
|
Optimer Pharmaceuticals Inc |
OPTR |
Director |
2013-10-24 |
0 |
2013-10-24 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NUS |
NU Skin Enterprises Inc |
Chief Scientific Officer |
• – – |
2013-11-11 |
4 |
AS |
$111.63 |
$6,202,498 |
D/D |
(55,563) |
99,097 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific Officer |
• – – |
2011-07-18 |
4 |
AS |
$40.00 |
$3,837,840 |
D/D |
(95,946) |
100,478 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific Officer |
• – – |
2014-12-20 |
4 |
D |
$43.55 |
$3,479,035 |
D/D |
(79,886) |
112,896 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific Officer |
• – – |
2023-03-01 |
4 |
S |
$40.44 |
$2,769,533 |
D/D |
(68,485) |
21,234 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific Officer |
• – – |
2017-11-10 |
4 |
S |
$62.24 |
$2,271,947 |
D/D |
(36,503) |
53,066 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific Officer |
• – – |
2023-03-01 |
4 |
OE |
$30.63 |
$2,097,696 |
D/D |
68,485 |
89,719 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific Officer |
• – – |
2012-04-25 |
4 |
S |
$60.02 |
$1,995,605 |
D/D |
(33,249) |
100,018 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific Officer |
• – – |
2014-12-20 |
4 |
OE |
$16.50 |
$1,980,000 |
D/D |
120,000 |
192,782 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific Officer |
• – – |
2010-10-08 |
4 |
OE |
$30.00 |
$1,875,000 |
D/D |
62,500 |
102,516 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific Officer |
• – – |
2020-06-05 |
4 |
S |
$40.01 |
$1,399,150 |
D/D |
(34,970) |
37,882 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific Officer |
• – – |
2011-07-18 |
4 |
OE |
$9.40 |
$1,386,516 |
D/D |
95,946 |
196,424 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific Officer |
• – – |
2022-03-01 |
4 |
AS |
$45.21 |
$1,292,213 |
D/D |
(28,577) |
22,957 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific Officer |
• – – |
2013-11-11 |
4 |
OE |
$17.03 |
$1,273,663 |
D/D |
55,563 |
154,660 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific Officer |
• – – |
2017-11-10 |
4 |
OE |
$30.43 |
$1,110,786 |
D/D |
36,503 |
89,569 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific Officer |
• – – |
2023-03-02 |
4 |
S |
$40.77 |
$1,019,250 |
D/D |
(25,000) |
21,234 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific Officer |
• – – |
2010-03-08 |
4 |
AS |
$29.00 |
$983,593 |
D/D |
(33,917) |
102,671 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
President-Pharmanex Division |
• – – |
2004-08-02 |
4 |
S |
$26.63 |
$932,050 |
D/D |
(35,000) |
2,131 |
|
- |
|
| NUS |
NU Skin Enterprises Inc |
President-Pharmanex Division |
• – – |
2003-10-31 |
4 |
S |
$15.57 |
$896,567 |
D/D |
(57,583) |
2,131 |
|
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific Officer |
• – – |
2022-03-01 |
4 |
OE |
$30.63 |
$875,314 |
D/D |
28,577 |
51,534 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific Officer |
• – – |
2017-11-08 |
4 |
S |
$62.06 |
$837,624 |
D/D |
(13,497) |
53,066 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific Officer |
• – – |
2018-08-08 |
4 |
S |
$82.02 |
$820,200 |
D/D |
(10,000) |
59,416 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific Officer |
• – – |
2023-03-02 |
4 |
OE |
$30.45 |
$761,358 |
D/D |
25,000 |
46,234 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
EVP, Chief Scientific Officer |
• – – |
2021-09-13 |
4 |
AS |
$47.41 |
$758,560 |
D/D |
(16,000) |
17,942 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific Officer |
• – – |
2022-06-01 |
4 |
AS |
$46.25 |
$745,058 |
D/D |
(16,000) |
22,957 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific Officer |
• – – |
2018-08-07 |
4 |
S |
$84.21 |
$715,785 |
D/D |
(8,500) |
59,416 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
